What the Hell Is Going on With Eligibility for COVID-19 Boosters?

Inconsistent messaging around who should receive another shot could sow further distrust in public health officials.

Biden booster

Evan Vucci/AP

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

For most people, the issue of COVID-19 boosters essentially boils down to “Should I get one or not?” But due to muddled messaging from federal agencies, it’s been difficult to get a direct answer to that seemingly straightforward question. 

The evidence is clear that even without boosters, the COVID-19 vaccines are still highly effective at preventing hospitalization and death—the mortality risk for an unvaccinated person is 10 times higher than for a vaccinated person. But some studies have shown that their protection against infection has started to wane, and some experts worry about a potential surge in cases as the weather cools and people begin to huddle indoors. Experts believe boosters will help address these concerns.

It’s likely that some of the confusion around boosters will clear up if and when they become widely available. The New York Times reported Tuesday night that the FDA is aiming to authorize Pfizer boosters for all adults this week without consulting its expert panel, which recommended against boosters for all individuals under 65 in a September vote. 

But up until this point, people trying to determine their third-dose eligibility have had to sort through a blizzard of developments and contradictory rulings. (Buckle up. It’s about to get complicated.) On September 17, the Food and Drug Administration’s advisory panel voted against Pfizer’s request to authorize boosters for all people 18 and older, instead recommending them only for high-risk individuals, those above 65, and those who work in jobs or live in institutions where they’re likely to get exposed to the coronavirus. A week later, a different panel advising the Centers for Disease Control and Prevention partially disagreed with the FDA panel’s decision, saying that a high-risk job shouldn’t qualify people for a booster. And then in a decision issued around midnight, CDC director Rochelle Walensky overruled the CDC panel, bringing the CDC’s guidelines in step with the FDA’s. The CDC also recommends that all people two months past a single Johnson & Johnson dose receive a booster shot. And those who fall under the eligible categories are free to mix and match vaccines. 

Meanwhile Colorado, California, New Mexico, and New York City barreled past current federal guidelines, allowing people 18 and up to get boosters, provided that they are six months past the second dose of an mRNA vaccine (that is, Pfizer or Moderna), or two months past a single dose of the Johnson & Johnson vaccine. Some of these jurisdictions justified the move by declaring large geographic regions—entire states or cities—to be high-risk “institutions,” thereby making all people who live within their borders eligible for a booster. 

If you’re anything like me, your head is probably throbbing at this point. And that’s not a great place to be while contemplating a decision about your health. 

Infectious disease epidemiologist Jessica Malaty Rivera said that the inconsistent messaging around boosters could further worsen distrust in public health officials. “When the messages don’t line up from this body to that body, from this official to that official, it creates distrust,” she said. “It makes people go rogue on their own risk assessments.”

Some experts have gone even further. Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration, called the messaging over booster shots “one of the biggest missed opportunities in this pandemic” in an interview on CBS’s Face the Nation. “Anyone who’s eligible for a booster, and most Americans probably are eligible for a booster at this point, should be going out and seeking it,” he said. 

In practice, however, it might not be so complicated. Since most vaccine providers ask people to self-attest to their eligibility, third doses are widely available around the United States, even to those who may not technically meet the FDA and CDC requirements. FDA authorization for a Pfizer booster would bring federal recommendations in line with what, in many cases, is already happening on the ground. 

The CDC’s interim clinical considerations regarding booster shots are also currently broad enough that most people could reasonably claim to meet them, said L.J. Tan, chief strategy officer for the Immunization Action Coalition, a vaccine information organization that works with the CDC. Tan pointed to one provision in the document that cites “an inability to work or meet other personal obligations when infected, even if not severely ill with COVID-19,” as a reason for considering a booster dose.

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate